Pharsight

Drugs that contain Venlafaxine Besylate

1. Venlafaxine Besylate patents expiration

VENLAFAXINE BESYLATE Litigations
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6717015 ALMATICA Venlafaxine besylate
Mar, 2023

(1 year, 25 days ago)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7776358 ALMATICA Extended release venlafaxine besylate tablets
May, 2028

(4 years from now)

Market Authorisation Date: 29 June, 2022

Treatment: Treatment of depression and generalized anxiety disorder

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage

VENLAFAXINE BESYLATE family patents

Family Patents